Shopping Cart
- Remove All
- Your shopping cart is currently empty
CSV0C018875 is a quinoline-based EHMT2/G9a inhibitor that exhibits lower cytotoxicity compared to BIX-01294 [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,520 | 6-8 weeks | |
50 mg | $1,980 | 6-8 weeks | |
100 mg | $2,500 | 6-8 weeks |
Description | CSV0C018875 is a quinoline-based EHMT2/G9a inhibitor that exhibits lower cytotoxicity compared to BIX-01294 [1]. |
In vitro | CSV0C018875, at concentrations ranging from 2.5 to 20 μM over a 48-hour period, reduces H3K9me2 modification levels in histones [1]. Through Western Blot Analysis [1] conducted on HEK293 cells, with doses of 2.5 μM, 10 μM, and 20 μM, it was observed that CSV0C018875 progressively inhibits G9a enzymatic activity in a dose-dependent manner. |
Molecular Weight | 312.79 |
Formula | C18H17ClN2O |
Cas No. | 442150-41-6 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.